ProQR Therapeutics (PRQR) Capital Expenditures (2013 - 2026)
ProQR Therapeutics (PRQR) posted Capital Expenditures of -$338,247 for the quarter ended Jun 30, 2026, compared with -$114,328 a year earlier.
Powered by 
Analysis
ProQR Therapeutics (PRQR) Capital Expenditures (2013 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Capital Expenditures at ProQR Therapeutics was -$1.34 million; for the year ended Dec 31, 2025, it came in at -$1.15 million.
- In prior years, ProQR Therapeutics' Capital Expenditures was -$1.53 million in the year ended Dec 31, 2024, -$1.48 million in the year ended Dec 31, 2023, -$746,201 in the year ended Dec 31, 2022 and -$572,764 in the year ended Dec 31, 2021.
- Quarterly Capital Expenditures has run from a low of -$795,217 in the quarter ended Mar 31, 2024 to a high of $13,263 in the quarter ended Dec 31, 2022 over five years.
- According to Business Quant data, Capital Expenditures for the three prior quarters was -$192,002 (quarter ended Mar 31, 2026), -$612,287 (quarter ended Dec 31, 2025) and -$197,570 (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 2.93 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 1.32 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 322.00 Mn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 893.00 Mn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -321.00 Mn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -763.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 513.00 Mn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 140.00 Mn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 533.00 Mn |
| 10 | ProQR Therapeutics | 171.74 Mn | -291.86 Mn | - | -338,247.30 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -338,247.30 |
| Mar 31, 2026 | -192,002.29 |
| Dec 31, 2025 | -612,286.89 |
| Sep 30, 2025 | -197,570.31 |
| Jun 30, 2025 | -114,327.93 |
| Mar 31, 2025 | -235,622.11 |
| Dec 31, 2024 | -142,123.19 |
| Sep 30, 2024 | -314,090.78 |
| Jun 30, 2024 | -287,528.98 |
| Mar 31, 2024 | -795,216.81 |
| Dec 31, 2023 | -647,715.83 |
| Sep 30, 2023 | -369,032.17 |
| Jun 30, 2023 | -320,143.77 |
| Mar 31, 2023 | -145,974.49 |
| Dec 31, 2022 | 13,263.22 |
| Sep 30, 2022 | -248,035.49 |
| Jun 30, 2022 | -246,490.09 |
| Mar 31, 2022 | -273,850.40 |
| Dec 31, 2021 | -257,393.46 |
| Sep 30, 2021 | -206,375.28 |
API Access
ProQR Therapeutics Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=PRQR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "PRQR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=PRQR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();